Key result
CCTA-determined three-vessel or left main disease is linked to ~341% greater risk of major events.
Why the study?
The 3.5-year prognosis of stable coronary artery disease evaluated by coronary computed tomography angiography in real-world clinical practice, overall and across demographic and comorbidity subgroups, needed examination.
Does the severity of coronary artery disease determined by CCTA predict the risk of late revascularization, myocardial infarction, and all-cause death in patients with new-onset symptoms suggestive of CAD?
Cohort (n=16,949)
Yes
Does the severity of coronary artery disease determined by CCTA predict the risk of late revascularization, myocardial infarction, and all-cause death in patients with new-onset symptoms suggestive of CAD?
CCTA-determined CAD severity strongly predicts the 3.5-year risk of late revascularization, myocardial infarction, and death in patients with stable symptoms.
Answers are grounded in this paper and cite their sources.
CCTA stratifies 3.5-year risk in symptomatic stable CAD; extends prior cohorts but leaves open effects on management and outcomes.
Aims: To examine the 3.5 year prognosis of stable coronary artery disease (CAD) as assessed by coronary computed tomography angiography (CCTA) in real-world clinical practice, overall and within subgroups of patients according to age, sex, and comorbidity. Methods and results: This cohort study included 16,949 patients (median age 57 years; 57% women) with new-onset symptoms suggestive of CAD, who underwent CCTA between January 2008 and December 2012. The endpoint was a composite of late coronary revascularization procedure >90 days after CCTA, myocardial infarction, and all-cause death. The Kaplan-Meier estimator was used to compute 91 day to 3.5 year risk according to the CAD severity. Comparisons between patients with and without CAD were based on Cox-regression adjusted for age, sex, comorbidity, cardiovascular risk factors, concomitant cardiac medications, and post-CCTA treatment within 90 days. The composite endpoint occurred in 486 patients. Risk of the composite endpoint was 1.5% for patients without CAD, 6.8% for obstructive CAD, and 15% for three-vessel/left main disease. Compared with patients without CAD, higher relative risk of the composite endpoint was observed for non-obstructive CAD [hazard ratio (HR): 1.28; 95% confidence interval (CI): 1.01-1.63], obstructive one-vessel CAD (HR: 1.83; 95% CI: 1.37-2.44), two-vessel CAD (HR: 2.97; 95% CI: 2.09-4.22), and three-vessel/left main CAD (HR: 4.41; 95% CI :2.90-6.69). The results were consistent in strata of age, sex, and comorbidity. Conclusion: Coronary artery disease determined by CCTA in real-world practice predicts the 3.5 year composite risk of late revascularization, myocardial infarction, and all-cause death across different groups of age, sex, or comorbidity burden.
No takes yet. Share an insight, caveat, or question.
Nielsen et al. (2016) conducted a cohort in stable coronary artery disease (n=16,949). Coronary computed tomography angiography (CCTA) vs. Patients without CAD was evaluated on composite of late coronary revascularization procedure >90 days after CCTA, myocardial infarction, and all-cause death (HR 4.41, 95% CI 2.90-6.69). CCTA-determined CAD severity predicted the 3.5-year risk of late revascularization, MI, and death, with hazard ratios up to 4.41 for three-vessel/left main disease.
Synapse has enriched 10 related papers. Consider them for comparative context: